Stay updated on Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.

Latest updates to the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page
- Check7 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a newer version of the page's content or code. This update largely reflects internal maintenance and does not alter the study details or displayed information.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now indicates recruitment is closed, signaling no participant enrollment. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), updates the revision label to v3.6.0, and adjusts the Intervention/Treatment header formatting.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page is now live. This appears to be a metadata/maintenance update rather than a substantive change to the study details.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision label updated from v3.5.3 to v3.5.4, indicating a minor update to the page framework without changes to study content.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page footer revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor ClinicalTrials.gov site release.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.